Innovating CNS Disease Modeling: Tailoring Cells & Editing Genomes
Originally aired on March 26, 2020
Evolving in vitro models provide powerful platforms to unravel disease mechanisms and translate this knowledge to useful therapeutics. This Cell Press Webinar will focus on the application of recent genomic and cellular engineering technologies, including CRISPR and organoids, to model neurological indications.
In this webinar, you'll hear from three leaders in the field: Kristen Brennand (Icahn School of Medicine at Mount Sinai), Stanley Qi (Stanford University), and Madeline Lancaster (MRC Laboratory of Molecular Biology). Each will present work done in their labs that enables the development of in vitro cellular platforms from healthy individuals and patients, and elaborate on the results of their investigations.
Department of Genetics and Genomic Sciences,
Nash Family Department of Neuroscience,
Department of Psychiatry,
Icahn School of Medicine at Mount Sinai
Department of Bioengineering
Department of Chemical and Systems Biology